Related Experiment Video
Updated: Jun 18, 2026
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Cellular cardiomyoplasty and cardiac regeneration
Lakshmana Pendyala1, Traci Goodchild, Radhika R Gadesam
1Saint Joseph's Translational Research Institute / Saint Joseph's Hospital of Atlanta, GA, USA.
Insights
Cardiac cell therapy offers hope for heart failure (HF) by regenerating heart muscle. Research is exploring various cell types and methods to improve outcomes after myocardial infarction.
Area of Science:
- Regenerative Medicine
- Cardiology
- Biotechnology
Background:
- Myocardial infarction (MI) frequently leads to heart failure (HF), a major cause of mortality.
- Current treatments for severe HF, excluding heart transplantation, have limited efficacy.
- Cardiac cell therapy, or cellular cardiomyoplasty, is a promising regenerative approach for cardiac repair.
Purpose of the Study:
- To review recent literature on cell-based therapies for cardiac regeneration.
- To examine the in vitro cardiogenic potential of various cell types.
- To assess the in vivo engraftment and functional improvement capacity of transplanted cells in infarcted hearts.
Main Methods:
- Literature review of preclinical and clinical studies on cardiac cell therapy.
- Analysis of in vitro data on the differentiation and function of cardiac progenitor cells.
- Evaluation of in vivo studies assessing cell survival, integration, and functional recovery post-myocardial infarction.
Main Results:
- Cell transplantation has shown feasibility, safety, and potential effectiveness in human clinical studies.
- Various cell types are being investigated for their potential in myocardial regeneration.
- Optimal cell source, number, and delivery methods for cellular cardiomyoplasty are still under investigation.
Conclusions:
- Cell-based myocardial regeneration is a developing therapeutic strategy for diverse cardiac conditions.
- Further research is needed to define the ideal parameters for successful cardiac cell therapy.
- Cellular cardiomyoplasty holds significant promise for treating heart failure and improving cardiac function.
Abstract:
Despite of vast improvements in treatment, myocardial infarction often leads to heart failure (HF) which remains the leading cause of death in developed countries. Other than heart transplantation, therapeutic options have a limited role in improving out comes in patients with severe HF. It is therefore no surprise that cardiac cell therapy has raised many hopes as a novel therapeutic approach aimed at cardiac myocyte replacement/regeneration termed "cellular cardiomyoplasty". However, the ideal source, cell type, critical cell number, and mode of application for optimal therapeutic effect have not been defined thus far. Recent observations of the beneficial effect of cell transplantation in animal experiments have generated tremendous excitement and stimulated clinical studies suggesting that this approach is feasible, safe, and potentially effective in humans. Cell-based myocardial regeneration is currently being explored for a wide range of cardiac disease states, including acute and chronic ischemic myocardial damage, cardiomyopathy and as biological heart pacemakers. The main purpose of this article is to review recent literature on the use of various cells for the examination of their in vitro cardiogenic potential and their in vivo capacity to engraft and improve the functional properties of the infarcted heart.
